GBA1相关帕金森病认知衰退模式:探索性纵向多队列研究
该多队列研究比较了211例GBA1突变帕金森病患者、903例无突变患者和546名健康对照的认知轨迹,发现GBA1突变患者执行、注意、视认知和记忆基线更差且衰退更快,加工速度和视知觉损害最早出现,分别早于无突变患者1.2和2.5疾病年,并识别出快速衰退亚组。
要点
- GBA1突变帕金森病患者认知损害更广泛且衰退更快。
- 加工速度和视知觉损害最早出现,分别早1.2和2.5疾病年。
- 快速衰退亚组更多为男性、有抑郁症状和严重GBA1突变。
核心结论
- GBA1突变帕金森病患者较无突变患者表现出加速的、跨认知域的且更严重的认知衰退。
研究设计与样本
- 探索性纵向多队列研究,纳入PPMI、ABC-PD和NCER-PD三个队列,共546名健康对照、903例GBA1野生型帕金森病患者和211例GBA1突变帕金森病患者。
- 采用标准化神经心理评估,使用广义线性混合效应模型评估各认知域表现,并进行探索性潜在轨迹分析、至首次事件模型和时间窗扩展方法。
主要发现
- GBA1突变患者在基线时执行功能、注意力、视认知技能和记忆均差于无突变患者,且在这些领域衰退更快速和广泛。
- GBA1突变患者病程中发生临床相关认知损害的风险增加。
- 加工速度和视知觉在GBA1突变患者中最早出现损害,分别早于无突变患者1.2和2.5疾病年。
- GBA1突变组内识别出快速认知衰退亚组,该亚组更可能为男性、报告抑郁症状并携带严重GBA1突变。
关键数值与推荐
- 临床相关表现损害定义为测验分数z≤-1.5或蒙特利尔认知评估(MoCA)<26。
临床怎么用
- 对GBA1突变帕金森病患者应关注执行、注意、视认知和记忆等多域认知损害,并警惕更快速的衰退轨迹。
- 加工速度和视知觉可作为GBA1突变患者早期认知损害的敏感指标,可考虑优先监测。
- 男性、伴抑郁症状或携带严重GBA1突变的患者可能属于快速认知衰退高危亚组,需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: People with Parkinson's disease (PD) who carry a pathogenic GBA1 variant (PDGBA1) are at higher risk of cognitive impairment than those without the variant (PDGBA1_wildtype). To date, little is known about the pattern and evolution of cognitive decline in PDGBA1. This multicenter study characterized the cognitive profile of PDGBA, focusing on the longitudinal trajectories and the group-specific onset times among cognitive functions, as well as their clinical relevance. METHODS: In this exploratory longitudinal multicohort-study (Parkinson's Precision Medicine Initiative [PPMI], Amyloid-Beta in cerebrospinal spinal fluid as a risk factor for cognitive dysfunction in Parkinson's Disease [ABC-PD], and National Centre for Excellence in Research on Parkinson's disease [NCER-PD]), comprehensive neuropsychological assessments were standardized across 546 healthy controls (follow-up years = 2.9 ± 4.3), 903 PDGBA1_wildtype (follow-up years = 4.4 ± 4.2), and 211 PDGBA1 (follow-up years = 4.8 ± 3.4). We evaluated performance across age and disease duration using generalized linear mixed effects models (GLMMs) within each cognitive domain. An exploratory latent trajectory analysis was computed to identify potential cognitive subgroups. Time-to-first-event models, assessing risks of clinically relevant performance impairment (test score z ≤ -1.5, Montreal Cognitive Assessment [MoCA] < 26), and an expanding time-window approach identified the course of cognitive impairment. RESULTS: PDGBA1 performed worse in executive function, attention, visuocognitive skills, and memory than PDGBA1_wildtype at baseline and exhibited a more rapid and widespread decline across these domains. The risk of developing clinically relevant cognitive impairment during the disease course was increased in PDGBA1. Processing speed and visuoperceptual showed the earliest performance impairments in PDGBA1, preceding PDGBA1_wildtype by 1.2 and 2.5 disease years, respectively. Within the PDGBA1 group, we identified a subgroup with rapidly declining cognition, who were more likely to be male patients, report depressive symptoms, and carry a severe GBA1 mutation. INTERPRETATION: PDGBA1 exhibits accelerated domain-generalized and more severe cognitive decline compared to PDGBA1_wildtype. ANN NEUROL 2026.
引用
- Bode M, Pauly C, Jónsdóttir SR, et al. Understanding the Pattern of Cognitive Decline in GBA1-Related Parkinson's Disease: An Exploratory Longitudinal Multi-Cohort Study. Ann Neurol. 2026. PMID: 42969188. doi:10.1002/ana.78362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。